What is the address of SAEM-4U?

The registered office of SAEM-4U is located at Onderstraat 7 box 211, 9000 Gent.

Is SAEM-4U still active?

Yes. According to the CBE (30 October 2026) SAEM-4U is active, legal situation “Normale toestand”, started on 14 July 2015.

Is SAEM-4U registered on Peppol?

Yes, SAEM-4U is registered on the Peppol network with ID 0208:0633841451.

What is the enterprise number of SAEM-4U?

The enterprise number of SAEM-4U is BE0633841451.

When was SAEM-4U founded?

SAEM-4U was founded on 14 July 2015.

Who are the directors of SAEM-4U?

According to the 2025 annual accounts, the directors of SAEM-4U are: Emil POT.

Is SAEM-4U a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 July 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SAEM-4U make in 2025?

SAEM-4U posted a profit after taxes of € 40,287 in financial year 2025.

What is the revenue of SAEM-4U?

As a small company, SAEM-4U is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 78,393.

How many employees does SAEM-4U have?

According to the 2025 annual accounts, SAEM-4U has 0 full-time equivalents (FTE).

SAEM-4U (Private Limited) - Gent - BE0633841451

Q: What does SAEM-4U do?

SAEM-4U is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 14 July 2015, 1 establishment.

Dossier SAEM-4U, printed on 30 October 2026 from databakkes.be/en/0633841451/saem-4u. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 51 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

SAEM-4U from Gent, company number BE0633841451, closed financial year 2025 with a result of € 40,287 after tax. For that financial year SAEM-4U recorded a gross margin of € 78,393 and equity of € 48,600. Compared with financial year 2024, the result moved from € -21,972 to € 40,287. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 28, 2026.

What it is worth Growing

€ 48,600

▲ 79% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 40,287

▲ still € 21,972 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,564

▼ 95% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 18,877 paid out

47 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 810

▼ 91% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 179,493

▼ 21% vs 2024

€ 49,334 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,017

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,996

▼ 77% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 101,406 Gross margin 2022: € 101,406 First fiscal year in the series	€ 146,784 Gross margin 2023: € 146,784 ▲ 45% vs 2022 (€ 101,406) Favourable step	€ 100,697 Gross margin 2024: € 100,697 ▼ 31% vs 2023 (€ 146,784) Unfavourable step	€ 78,393 Gross margin 2025: € 78,393 ▼ 22% vs 2024 (€ 100,697) Unfavourable step	▼ 22%
Profit after taxes	€ 43,971 Profit after taxes 2022: € 43,971 First fiscal year in the series	€ 46,544 Profit after taxes 2023: € 46,544 ▲ 6% vs 2022 (€ 43,971) Favourable step	€ -21,972 Profit after taxes 2024: € -21,972 ▼ € 68,516 vs 2023 (€ 46,544) Unfavourable step	€ 40,287 Profit after taxes 2025: € 40,287 ▲ € 62,259 vs 2024 (€ -21,972) Favourable step	▲ € 62,259
Equity	€ 254,797 Equity 2022: € 254,797 First fiscal year in the series	€ 301,341 Equity 2023: € 301,341 ▲ 18% vs 2022 (€ 254,797) Favourable step	€ 27,189 Equity 2024: € 27,189 ▼ 91% vs 2023 (€ 301,341) Unfavourable step	€ 48,600 Equity 2025: € 48,600 ▲ 79% vs 2024 (€ 27,189) Favourable step	▲ 79%
Total debts	€ 421,031 Total debts 2022: € 421,031 First fiscal year in the series	€ 346,683 Total debts 2023: € 346,683 ▼ 18% vs 2022 (€ 421,031) Favourable step	€ 523,160 Total debts 2024: € 523,160 ▲ 51% vs 2023 (€ 346,683) Unfavourable step	€ 277,127 Total debts 2025: € 277,127 ▼ 47% vs 2024 (€ 523,160) Favourable step	▼ 47%
Cash	€ 145,490 Cash 2022: € 145,490 First fiscal year in the series	€ 246,680 Cash 2023: € 246,680 ▲ 70% vs 2022 (€ 145,490) Favourable step	€ 244,249 Cash 2024: € 244,249 ▼ 1% vs 2023 (€ 246,680) Unfavourable step	€ 12,564 Cash 2025: € 12,564 ▼ 95% vs 2024 (€ 244,249) Unfavourable step	▼ 95%
Land & buildings	€ 272,575 Land & buildings 2022: € 272,575 First fiscal year in the series	€ 262,663 Land & buildings 2023: € 262,663 ▼ 4% vs 2022 (€ 272,575) Unchanged	€ 253,404 Land & buildings 2024: € 253,404 ▼ 4% vs 2023 (€ 262,663) Unchanged	€ 244,705 Land & buildings 2025: € 244,705 ▼ 3% vs 2024 (€ 253,404) Unchanged	▼ 3%
Retained profit	€ 236,197 Retained profit 2022: € 236,197 First fiscal year in the series	€ 282,741 Retained profit 2023: € 282,741 ▲ 20% vs 2022 (€ 236,197) Favourable step	€ 8,589 Retained profit 2024: € 8,589 ▼ 97% vs 2023 (€ 282,741) Unfavourable step	€ 30,000 Retained profit 2025: € 30,000 ▲ 249% vs 2024 (€ 8,589) Favourable step	▲ 249%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 252,180 Dividend 2024: € 252,180 Unchanged (€ 0) Unchanged	€ 18,877 Dividend 2025: € 18,877 ▼ 93% vs 2024 (€ 252,180) Unchanged	▼ 93%
Bank debt	€ 325,058 Bank debt 2022: € 325,058 First fiscal year in the series	€ 274,895 Bank debt 2023: € 274,895 ▼ 15% vs 2022 (€ 325,058) Favourable step	€ 227,729 Bank debt 2024: € 227,729 ▼ 17% vs 2023 (€ 274,895) Favourable step	€ 179,493 Bank debt 2025: € 179,493 ▼ 21% vs 2024 (€ 227,729) Favourable step	▼ 21%
Balance sheet total	€ 675,828 Balance sheet total 2022: € 675,828 First fiscal year in the series	€ 648,024 Balance sheet total 2023: € 648,024 ▼ 4% vs 2022 (€ 675,828) Unchanged	€ 550,349 Balance sheet total 2024: € 550,349 ▼ 15% vs 2023 (€ 648,024) Unchanged	€ 325,727 Balance sheet total 2025: € 325,727 ▼ 41% vs 2024 (€ 550,349) Unchanged	▼ 41%

Key figures of SAEM-4U, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SAEM-4U?

What happened at SAEM-4U in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 28, 2026 New annual accounts for financial year 2025: profit of € 40,287. Source: NBB ↗
Jul 14, 2015 New establishment in Gent. KBO
Jul 14, 2015 Start of the company according to the CBE. KBO
2015 Emil POT became a director. NBB

In short

From € 43,971 profit in 2022 to € 40,287 profit in 2025.

Paid € 76,076 in corporate taxes since 2022.

Best year ever: 2023, with € 46,544 profit.

Paid out € 271,057 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Emil POT

SAEM-4U

Allero Therapeutics 100%

Behind SAEM-4U is Emil POT. It owns 100% of Allero Therapeutics itself.

Directors

According to the 2025 annual accounts

Emil POT

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Onderstraat 7 box 211

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Lab No.8

€ 6,118 gross margin · 2025

Allero Therapeutics same network

€ -2,308 gross margin · 2025

Eleven Ways

€ 502,284 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0633.841.451

VAT number

BE 0633.841.451

Registered office

Onderstraat 7 bus 211, 9000 Gent

Names & denominations

SAEM-4U

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 July 2015

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

SAEM-4U

Warning lights

Financials

What happened to SAEM-4U?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions